Partnering opportunities - Out licensing and divestments Out licensing and divestments Novartis is open to discussing the divestment of certain commercial products in different regions, as well as granting licenses to development-stage compounds that have been de-prioritized due to strategic reasons. Out licensingSven WernerContact DivestmentsJean Marc SéquierContact PrintPDF
